Qualigen Therapeutics, Inc. — Director's Dealing 2017

Feb 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-02-27

Reporting Person: Step Michael D (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-27	Common Stock	P	2000	$2.64	Acquired	29000	Indirect
2017-02-27	Common Stock	P	8000	$2.65	Acquired	37000	Indirect

Footnotes

F1: The reporting person's prior Form 4s erroneously reported that the reporting person holds his shares directly. However, the reporting person holds his shares indirectly through the Michael D. Step Family Trust, and always has.